Delivery Order SPE2DB22D2206-SPE2DB23FJF97
Award Date 7/18/23
Potential Completion Date 7/19/23
Potential Value $14K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $9,023.10 to Amerisourcebergen Drug Corporation for the supply of 4561722055 RINVOQ ER 15 MG tablets. Amerisourcebergen Drug Corporation will deliver 30 units of the specified medication to a facility located in Conshohocken, Pennsylvania by August 8, 2023 to fulfill requirements under the contract. As a major provider of medical supplies and pharmaceuticals to the U.S. Department of Defense, the Defense Logistics...
- The Defense Logistics Agency awarded a $21,635 delivery order contract to Amerisourcebergen Drug Corporation for 4562194640 RINVOQ ER 45 MG tablets. The firm fixed price contract calls for Amerisourcebergen to deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 18, 2023 in support of DLA programs. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will likely fulfill this order from its existing inventory and distribution...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $6,015.40 to Amerisourcebergen Drug Corporation for the supply of 4561961471 RINVOQ ER 15 MG tablets. Amerisourcebergen Drug Corporation will deliver 30 units of the specified medication to a location in Conshohocken, Pennsylvania by August 29, 2023 in performance of this order. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen Drug Corporation and its parent company...
- The Defense Logistics Agency awarded a $35,178 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562114320 RINVOQ ER 15 MG tablets. Under this order, Amerisourcebergen will deliver 30 bottles of the specified rheumatoid arthritis medication to a location in Conshohocken, Pennsylvania by September 12, 2023 in support of Department of Defense pharmacuetical needs. As a top 100 contractor on DLA's Pharmaceutical Prime Vendor contract, Amerisourcebergen routinely supplies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for RINVOQ ER 30 mg tablets in a quantity of 30 units, with a ceiling value of $9,594.18. This is a firm fixed-price, non-set-aside delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $30,354.57 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units). This is a firm fixed-price delivery order with no set-aside designation, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $26,156.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit of use packaging) on September 24, 2025, with completion targeted for September 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for RINVOQ ER 30 mg tablets (30-unit packages) valued at $10,378.45. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the primary vendor fulfilling this pharmaceutical requirement through its...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $38,226.39 to Amerisourcebergen Drug Corporation for the supply of 4561822369 RINVOQ ER 30 MG tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania over a period from August 15 to August 16, 2023. The Defense Logistics Agency manages the global supply chain for the United...
- The Defense Logistics Agency awarded a delivery order valued at $6,015.40 to Amerisourcebergen Drug Corporation for the supply of 4561740151 RINVOQ ER 15 MG tablets. Amerisourcebergen Drug Corporation will provide thirty units of the specified medication to fulfill requirements under the delivery order. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a one day period from August 8 to August 9, 2023. The contract utilizes a firm fixed price...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJF97Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,497.90 to Amerisourcebergen Drug Corporation for the supply of 4561533022 RINVOQ ER 45 MG tablets. Amerisourcebergen will deliver 28 units of the specified medication to a facility located in Conshohocken, Pennsylvania between July 18-19, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen was likely awarded this delivery order under the DLA's Pharmaceutical Prime Vendor contract to provide needed prescription drugs to military treatment facilities and beneficiaries. No subcontractors or set aside designations were indicated.
Generated 12/23/23, 3:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 7/18/23 |